Letter in response to recent paper by Fournier et al.
Dullaart
Robin P F
RP
van Tol
Arie
A
D001693:Biological Transport, Active / Q000502:physiology; D015415:Biomarkers / Q000032:analysis; D002352:Carrier Proteins / Q000097:blood / Q000378:metabolism*; D008076:Cholesterol, HDL / Q000097:blood / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D008565:Membrane Proteins / Q000097:blood / Q000378:metabolism*; D049294:Phospholipid Transfer Proteins; D015203:Reproducibility of Results; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D014280:Triglycerides / Q000032:analysis / Q000378:metabolism*
D015415:Biomarkers; D002352:Carrier Proteins; D008076:Cholesterol, HDL; D008565:Membrane Proteins; D049294:Phospholipid Transfer Proteins; D014280:Triglycerides